According to a new report North America Atherectomy Devices Market, published by KBV Research, the North America Atherectomy Devices Market would witness market growth of 6.15% CAGR during the forecast period (2019-2025).
The USA market dominated the North America Atherectomy Devices Market by Country in 2018, and would continue to be a dominant market till 2025; thereby, achieving a market value of $265.5 Million by 2025, growing at a CAGR of 5.7 % during the forecast period.The Canada market is expected to witness a CAGR of 6.5% during (2019 - 2025). Additionally, The Mexico market is expected to witness a CAGR of 8.5% during (2019 - 2025).
By Type, the Directional Atherectomy market dominated the North America Atherectomy Devices Market by Type in 2018, and would continue to be a dominant market till 2025; thereby, achieving a market value of $132.9 Million by 2025, growing at a CAGR of 5.4 % during the forecast period. The Rotational Atherectomy market is expected to witness a CAGR of 6.4% during (2019 - 2025).
Full Report:https://www.kbvresearch.com/north-america-atherectomy-devices-market/
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Cardiovascular Systems Inc., Avinger Inc., Straub Medical AG, Boston Scientific Corporation, Medtronic PLC (Covidien), Koninklijke Philips N.V., Cardinal Health, Inc. (Cordis), Terumo Corporation (Terumo IS), Abbott Laboratories and B. Braun Melsungen AG.
By Type
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
